Attached files
| file | filename |
|---|---|
| EX-10.1 - COLLABORATION AGREEMENT - VERENIUM CORP | d280253dex101.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K/A
Amendment No. 1
Current Report
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 23, 2011
VERENIUM CORPORATION
(Exact name of registrant as specified in its charter)
| Delaware | 000-29173 | 22-3297375 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
| 4955 Directors Place, San Diego, CA | 92121 | |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (800) 523-2990
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Explanatory Note
Verenium Corporation is filing this amendment to its Current Report on Form 8-K, originally filed with the Securities and Exchange Commission on June 27, 2011, as an exhibit-only filing solely for the purpose of amending Exhibit 10.1 filed with the Form 8-K to reflect changes made to portions of Exhibit 10.1.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
| Exhibit Number |
Description | |
| 10.1† | Collaboration Agreement dated as of June 23, 2011, by and between Verenium Corporation and Novus International, Inc. | |
| † | Confidential treatment has been requested with respect to certain portions of this exhibit. Omitted portions have been filed separately with the Securities and Exchange Commission. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| VERENIUM CORPORATION | ||||||
| Dated: January 10, 2012 | By: | /s/ James E. Levine | ||||
| Name: | James E. Levine | |||||
| Title: | President and Chief Executive Officer | |||||
EXHIBIT INDEX
| Exhibit Number |
Description | |
| 10.1† | Collaboration Agreement dated as of June 23, 2011, by and between Verenium Corporation and Novus International, Inc. | |
| † | Confidential treatment has been requested with respect to certain portions of this exhibit. Omitted portions have been filed separately with the Securities and Exchange Commission. |